GLOBAL ARTIFICIAL INTELLIGENCE IN ONCOLOGY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Global Artificial Intelligence in Oncology Market, By Component (Software/Platform, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others), By Treatment Type (Chemotherapy, Radiotherapy, Immunotherapy, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Biopharmaceutical Companies, Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Recent Developments:

In March 2023, Qritive, a Singapore-based AI startup involved in providing AI-based solutions for cancer diagnostics, announced that it had launched QAi Prostate, a new AI-based tool for the diagnosis of prostate cancer
In December 2022, MedCognetics, Inc., a U.S.-based cloud-based software provider, announced that it had received U.S. Food and Drug Administration (FDA) 510(k) clearance for its artificial intelligence (AI)-enabled software for breast cancer screening, QmTRIAGE.